mthompson45

ABBV BUY High Yield Growth Stock

Largo
NYSE:ABBV   AbbVie Inc.
ABBV is a High Yield Growth Stock on the move.

ABBV engages in the discovery, development, manufacture, and sale of pharmaceuticals worldwide. The company's offerings include pharmaceutical products such as autoimmune and intestinal disease therapy, HUMIRA, adult plaque psoriasis treatment, SKYRIZI, and adult rheumatoid arthritis treatment, RINVOQ.

On December 8, Allergan, an ABBV company, announced that its product VUITYâ„¢, the first U.S. Food and Drug Administration (FDA) approved eye drop to treat presbyopia, is now available by prescription in pharmacies nationwide. This should add to the company's revenue stream.

On December 6, ABBV announced positive top-line results from its U-EXCEED phase-3 induction study regarding the usage of Upadacitinib (RINVOQ®) to treat Crohn's disease. This demonstrates the company's expertise and should enable the company to cater to patients with this disease.
Exención de responsabilidad

La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.